Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alkermes (ALKS) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Alkermes (ALKS) over the last 16 years, with Q3 2025 value amounting to $616.4 million.

  • Alkermes' Cash & Equivalents rose 5555.38% to $616.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $616.4 million, marking a year-over-year increase of 5555.38%. This contributed to the annual value of $291.1 million for FY2024, which is 3635.72% down from last year.
  • Per Alkermes' latest filing, its Cash & Equivalents stood at $616.4 million for Q3 2025, which was up 5555.38% from $521.2 million recorded in Q2 2025.
  • In the past 5 years, Alkermes' Cash & Equivalents ranged from a high of $665.8 million in Q2 2023 and a low of $205.0 million during Q1 2021
  • In the last 5 years, Alkermes' Cash & Equivalents had a median value of $337.5 million in 2021 and averaged $393.6 million.
  • As far as peak fluctuations go, Alkermes' Cash & Equivalents soared by 16145.9% in 2023, and later tumbled by 3881.64% in 2024.
  • Quarter analysis of 5 years shows Alkermes' Cash & Equivalents stood at $337.5 million in 2021, then fell by 13.35% to $292.5 million in 2022, then soared by 56.41% to $457.5 million in 2023, then tumbled by 36.36% to $291.1 million in 2024, then skyrocketed by 111.73% to $616.4 million in 2025.
  • Its Cash & Equivalents was $616.4 million in Q3 2025, compared to $521.2 million in Q2 2025 and $399.8 million in Q1 2025.